BMC Psychiatry

official impact factor 2.89

Open Access Highly Access

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics

Douglas Faries, Haya Ascher-Svanum*, Baojin Zhu, Christoph Correll and John Kane

BMC Psychiatry 2005, 5:26 doi:10.1186/1471-244X-5-26

Accesses  

  • Last 30 days: 98 accesses
  • Last 365 days: 1053 accesses
  • All time: 8590 accesses

Cited by

BioMed Central: 5 citations